Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine and dexamethasone for extubation time and postoperative recovery in elderly patients
IRCT20180416039326N25Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine and dexamethasone in post-operative ocular pain, postoperative nausea and vomiting (PONV), cough and 1 more, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Extubation time and Quality of postoperative recovery. Started Nov 2025; status: completed.
02
Drugs
lidocainedexamethasone
03
Conditions
post-operative ocular painpostoperative nausea and vomiting (PONV)coughPost-extubation sore throat (POST)
Beyond the preview
Go deeper on IRCT20180416039326N25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N25.